Business Blog
1 minute reading time
(21 words)
Actavis in $66bn deal for Allergan
Actavis is buying Botox-maker Allergan for $66bn (£42bn) to create one of the top ten biggest pharmaceutical companies in the world.
Stay Informed
When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.
Comments